Atlas Trials

A Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in Chinese People

Clinical trial NCT05549206 · UNKNOWN

Trial details

NCT number
NCT05549206
Sponsor
AIM Vaccine Co., Ltd.
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
SARS-CoV-2
Start date
2023-04-01
Primary completion
2023-04-01
Enrollment
350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.